-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Context Capital Management LLC Purchases New Position in Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD)
Context Capital Management LLC Purchases New Position in Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD)
Context Capital Management LLC acquired a new stake in shares of Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD – Get Rating) during the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 135,339 shares of the company's stock, valued at approximately $1,353,000. Context Capital Management LLC owned approximately 0.48% of Intelligent Medicine Acquisition as of its most recent filing with the SEC.
Other large investors have also bought and sold shares of the company. Wolverine Asset Management LLC purchased a new stake in shares of Intelligent Medicine Acquisition in the 4th quarter worth $99,000. Lynwood Capital Management Inc. bought a new position in shares of Intelligent Medicine Acquisition in the 1st quarter valued at about $315,000. Starboard Value LP bought a new position in shares of Intelligent Medicine Acquisition in the 4th quarter valued at about $952,000. Radcliffe Capital Management L.P. bought a new position in shares of Intelligent Medicine Acquisition in the 4th quarter valued at about $2,970,000. Finally, Beryl Capital Management LLC purchased a new stake in Intelligent Medicine Acquisition in the 4th quarter worth about $5,594,000. 25.60% of the stock is owned by institutional investors.
Get Intelligent Medicine Acquisition alerts:Intelligent Medicine Acquisition Price Performance
Shares of NASDAQ:IQMD opened at $10.06 on Thursday. The firm's 50 day simple moving average is $10.01 and its 200-day simple moving average is $9.98. Intelligent Medicine Acquisition Corp. has a one year low of $9.86 and a one year high of $10.93.
Intelligent Medicine Acquisition Profile
(Get Rating)Intelligent Medicine Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science.
Further Reading
- Get a free copy of the StockNews.com research report on Intelligent Medicine Acquisition (IQMD)
- Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
- 3 Stable Growth Stocks for Bumpy Times
- Large And Small Oil-And-Gas Stocks See Post-Earnings Bounce
- The 2 Dow Stocks with Decade-Long Win Streaks on the Line
- Could Rite Aid Be an Acquisition Target, Again?
Want to see what other hedge funds are holding IQMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD – Get Rating).
Receive News & Ratings for Intelligent Medicine Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Medicine Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
Context Capital Management LLC acquired a new stake in shares of Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD – Get Rating) during the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 135,339 shares of the company's stock, valued at approximately $1,353,000. Context Capital Management LLC owned approximately 0.48% of Intelligent Medicine Acquisition as of its most recent filing with the SEC.
根據上下文資本管理有限公司與納斯達克的最新披露,該公司在第一季度收購了智能醫藥收購公司(Temasek Holdings:IQMD-Get Rating)的新股。該基金購買了135,339股該公司的股票,價值約為1,353,000美元。截至最近向美國證券交易委員會提交的文件,Context Capital Management LLC持有智能醫藥收購約0.48%的股份。
Other large investors have also bought and sold shares of the company. Wolverine Asset Management LLC purchased a new stake in shares of Intelligent Medicine Acquisition in the 4th quarter worth $99,000. Lynwood Capital Management Inc. bought a new position in shares of Intelligent Medicine Acquisition in the 1st quarter valued at about $315,000. Starboard Value LP bought a new position in shares of Intelligent Medicine Acquisition in the 4th quarter valued at about $952,000. Radcliffe Capital Management L.P. bought a new position in shares of Intelligent Medicine Acquisition in the 4th quarter valued at about $2,970,000. Finally, Beryl Capital Management LLC purchased a new stake in Intelligent Medicine Acquisition in the 4th quarter worth about $5,594,000. 25.60% of the stock is owned by institutional investors.
其他大型投資者也買賣了該公司的股票。金剛狼資產管理有限責任公司在第四季度購買了智能醫藥收購公司價值99,000美元的新股份。林伍德資本管理公司(Lynwood Capital Management Inc.)在第一季度購買了智能醫藥收購公司的新頭寸,價值約315,000美元。Starboard Value LP在第四季度購買了智能醫藥收購的新頭寸,價值約95.2萬美元。Radcliffe Capital Management L.P.在第四季度購買了智能醫藥收購的新頭寸,價值約297萬美元。最後,貝麗爾資本管理有限責任公司在第四季度購買了智能醫療收購的新股份,價值約559.4萬美元。25.60%的股票由機構投資者持有。
Intelligent Medicine Acquisition Price Performance
智能醫療採辦性價比
Shares of NASDAQ:IQMD opened at $10.06 on Thursday. The firm's 50 day simple moving average is $10.01 and its 200-day simple moving average is $9.98. Intelligent Medicine Acquisition Corp. has a one year low of $9.86 and a one year high of $10.93.
納斯達克:iqmd股價週四開盤報10.06美元。該公司的50日簡單移動均線切入位為10.01美元,200日簡單移動均線切入位為9.98美元。智能醫藥收購公司的股價一年來最低為9.86美元,一年最高為10.93美元。
Intelligent Medicine Acquisition Profile
智能醫療採集配置文件
Intelligent Medicine Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science.
智能醫藥收購公司沒有重大業務。公司專注於與一家或多家企業進行合併、資本換股、資產收購、股票購買、重組或相關業務合併。它打算確定生命科學領域的商業機會。
Further Reading
進一步閲讀
- Get a free copy of the StockNews.com research report on Intelligent Medicine Acquisition (IQMD)
- Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
- 3 Stable Growth Stocks for Bumpy Times
- Large And Small Oil-And-Gas Stocks See Post-Earnings Bounce
- The 2 Dow Stocks with Decade-Long Win Streaks on the Line
- Could Rite Aid Be an Acquisition Target, Again?
- 免費獲取StockNews.com關於智能醫學獲取(IQMD)的研究報告
- 清潔能源法案通過後,太陽能股大放異彩
- 顛簸時代的3只穩定成長股
- 大型和小型石油和天然氣類股盈利後反彈
- 連續十年上漲的兩隻道指股票
- Rite Aid會再次成為收購目標嗎?
Want to see what other hedge funds are holding IQMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD – Get Rating).
想看看還有哪些對衝基金持有IQMD嗎?訪問HoldingsChannel.com獲取智能醫藥收購公司(納斯達克代碼:iqmd-Get Rating)的最新13F備案文件和內幕交易信息。
Receive News & Ratings for Intelligent Medicine Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Medicine Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
接受《智能醫藥採購日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對智能醫藥收購和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧